MANILA, 14th January, 2021 (WAM/Reuters) — The Philippines’ Food and Drug Administration has authorised the emergency use of Pfizer Inc and BioNTech SE’s COVID-19 vaccine, its head said on Thursday.
The Pfizer-BioNTech vaccine, which has shown a 95 percent success rate, is the first vaccine the Philippines has approved.
FDA head Rolando Enrique Domingo told a media briefing China’s Sinovac Biotech Ltd on Wednesday submitted to regulators its emergency use authorisation application.

LEAVE A REPLY

Please enter your comment!
Please enter your name here